Survey of Oncologists in Europe


Survey of Oncologists in Europe

Expert-Backed Research


To understand the future impact of a new biosimilar entering the market for the treatment of HER2+ breast cancer.

Top Insights Collected

Insights into price negotiation and purchasing processes for oncology products in hospitals around Europe

Special focus on biosimilars and biologic therapies for immunology/inflammation and oncology

Quality of services offered by biosimilar manufacturers to support the quality of patient treatments

Atheneum Solution

30-min Survey of 100 targeted and pre-qualified physicians with oncology specialty, across 5 countries (FR, ES, DE, NL, PL)

Atheneum teams assisted respondents for the completion of the survey for understanding questions and technical issues